1. Home
  2. JRVR vs AMRN Comparison

JRVR vs AMRN Comparison

Compare JRVR & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JRVR
  • AMRN
  • Stock Information
  • Founded
  • JRVR 2002
  • AMRN 1989
  • Country
  • JRVR Bermuda
  • AMRN Ireland
  • Employees
  • JRVR N/A
  • AMRN N/A
  • Industry
  • JRVR Property-Casualty Insurers
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • JRVR Finance
  • AMRN Health Care
  • Exchange
  • JRVR Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • JRVR 261.1M
  • AMRN 216.0M
  • IPO Year
  • JRVR 2005
  • AMRN 1993
  • Fundamental
  • Price
  • JRVR $5.78
  • AMRN $12.64
  • Analyst Decision
  • JRVR Buy
  • AMRN Strong Sell
  • Analyst Count
  • JRVR 4
  • AMRN 1
  • Target Price
  • JRVR $6.06
  • AMRN $7.00
  • AVG Volume (30 Days)
  • JRVR 275.1K
  • AMRN 95.3K
  • Earning Date
  • JRVR 08-04-2025
  • AMRN 07-30-2025
  • Dividend Yield
  • JRVR 0.69%
  • AMRN N/A
  • EPS Growth
  • JRVR N/A
  • AMRN N/A
  • EPS
  • JRVR N/A
  • AMRN N/A
  • Revenue
  • JRVR $678,788,000.00
  • AMRN $214,112,000.00
  • Revenue This Year
  • JRVR $1.95
  • AMRN N/A
  • Revenue Next Year
  • JRVR $6.80
  • AMRN $7.88
  • P/E Ratio
  • JRVR N/A
  • AMRN N/A
  • Revenue Growth
  • JRVR N/A
  • AMRN N/A
  • 52 Week Low
  • JRVR $3.00
  • AMRN $7.08
  • 52 Week High
  • JRVR $8.99
  • AMRN $16.37
  • Technical
  • Relative Strength Index (RSI)
  • JRVR 58.21
  • AMRN 63.66
  • Support Level
  • JRVR $5.76
  • AMRN $12.80
  • Resistance Level
  • JRVR $6.04
  • AMRN $14.01
  • Average True Range (ATR)
  • JRVR 0.18
  • AMRN 0.80
  • MACD
  • JRVR -0.05
  • AMRN 0.04
  • Stochastic Oscillator
  • JRVR 55.00
  • AMRN 54.09

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: